Joining me today is Max Beyer, pharma reporter at Endpoints News and one of the sharpest voices covering pharma policy, pricing, and the biotech world. If you’ve seen the viral clip from Trump’s press event where he promised to drop the price of the so-called ‘fat shot’ to $150, that moment started with Max’s question. His work at Endpoints has been ahead of the curve on everything from Most Favored Nation drug pricing to the political tug-of-war that’s shaping the future of GLP-1 access in America. Max isn’t just writing about the drug industry, he’s talking to the people moving it, and today, we get to hear what it was like to be in the room when a single question shook the global obesity market.